ISRG Intuitive Surgical Inc.

Intuitive becomes largest robotic-assisted surgery provider to be accredited by the Royal College of Surgeons of England

Intuitive becomes largest robotic-assisted surgery provider to be accredited by the Royal College of Surgeons of England

SUNNYVALE, Calif., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Today, Intuitive announced that it has become the largest provider of robotic-assisted surgical technology training to be accredited by the Royal College of Surgeons of England (RCS England).

The accreditation, which has been awarded to Intuitive across its entire global education portfolio, is an award of excellence from RCS England in recognition of outstanding surgery-related education and is an internationally recognized hallmark of quality.

Intuitive is the pioneer of robotic-assisted surgery and provides training on its robotic technology to surgeons and their teams on its da Vinci Surgical Systems. To date, Intuitive has provided technology training to more than 60,000 surgeons worldwide.

The Royal College of Surgeons of England is a world leader of surgical education and provides quality assurance for any surgical training run in the UK and globally. The accreditation process is a review of the entire surgical education provider, its facilities, resources, and educational portfolio, and is only awarded where there is a clear demonstration of excellence in each of these components.

“We are proud that the Royal College of Surgeons has recognized Intuitive for the quality of our robotic surgery technology training and education, which combines technology and skills training with peer-to-peer learning. Achieving and maintaining a high standard of training are critical to realizing the benefits of robotic-assisted surgery for hospitals, surgeons, and patients,” said Dr. Gillian Duncan, Intuitive’s Senior Vice President of Professional Education.

“Intuitive is committed to providing technology training and education to surgeons and their teams. With nearly 30 years of experience in bringing robotic-assisted surgical systems and innovative technology to healthcare providers around the globe, we understand the vital role that training plays in any successful robotics program,” said Duncan.

“This accreditation gives assurance to the surgical community and to patients that training on this technology is being provided in a safe and standardized approach globally and will ensure that surgeons and their teams have confidence in their ability to use the tool, which is vital as new technology is adopted,” said Nuha Yassin, Consultant Colorectal Surgeon at The Royal Wolverhampton NHS Trust, and Council Member at the Royal College of Surgeons.

About Intuitive

Intuitive (Nasdaq: ISRG), headquartered in Sunnyvale, California, is a global leader in minimally invasive care and the pioneer of robotic surgery. Our technologies include the da Vinci surgical system and the Ion endoluminal system. By uniting advanced systems, progressive learning, and value-enhancing services, we help physicians and their teams optimize care delivery to support the best outcomes possible. At Intuitive, we envision a future of care that is less invasive and profoundly better, where diseases are identified early and treated quickly, so patients can get back to what matters most.

Please visit for more information.

Contact:

Peper Long

(202) 997-7373



EN
19/10/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Intuitive Surgical Inc.

 PRESS RELEASE

Da Vinci 5 Cleared for Cardiac Procedures

Da Vinci 5 Cleared for Cardiac Procedures FDA 510(k) clearance expands da Vinci 5 indications to include certain cardiac procedures SUNNYVALE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that the U.S. Food and Drug Administration (FDA) has cleared the da Vinci 5 system for certain cardiac procedures, including mitral valve repair and IMA (internal mammary artery) mobilization for cardiac revascularization.         Cardiovascular disease remains the l...

 PRESS RELEASE

20 Million Patients Benefit from da Vinci Surgery Globally

20 Million Patients Benefit from da Vinci Surgery Globally Achievement reflects the dedication of surgeons and care teams worldwide to improving patient outcomes through use of Intuitive’s minimally invasive technologies SUNNYVALE, Calif., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced that more than 20 million patients worldwide have been operated on by surgeons using da Vinci surgical systems. The milestone was reached as of the end of 2025, with more than 3.1 mil...

 PRESS RELEASE

Intuitive Announces Fourth Quarter Earnings

Intuitive Announces Fourth Quarter Earnings SUNNYVALE, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2025. Q4 Highlights Worldwide procedures (da Vinci and Ion combined) grew approximately 18% compared with the fourth quarter of 2024. Da Vinci procedures grew approximately 17% and Ion procedures grew approximately 44%.The Company placed 532 da Vinci surgical systems, compared with...

 PRESS RELEASE

Intuitive Announces Preliminary Fourth Quarter and Full Year 2025 Resu...

Intuitive Announces Preliminary Fourth Quarter and Full Year 2025 Results SUNNYVALE, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2025 financial results ahead of its presentation at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026. Financial and Operational Highlights Fourth quarter 2025 worldwide procedures (da Vinci and Ion combined) grew approximately 18...

 PRESS RELEASE

Intuitive Announces Expanded Indications for da Vinci SP

Intuitive Announces Expanded Indications for da Vinci SP FDA clearance expands da Vinci SP indications to include inguinal hernia repair, cholecystectomy, and appendectomy SUNNYVALE, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that the U.S. Food and Drug Administration (FDA) has cleared the da Vinci Single Port (SP) surgical system for use in inguinal hernia repair, cholecystectomy, and appendectomy procedures. These clearances expand da Vinci SP’s ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch